ENRIQUE
REY DÍAZ-RUBIO
Profesor titular de universidad
Publicacións (115) Publicacións de ENRIQUE REY DÍAZ-RUBIO
2023
-
Coffee ground emesis and early endoscopy: Is timing actually relevant?
Gastroenterologia y Hepatologia
2022
-
Abordaje de síntomas de diarrea y estreñimiento por el farmacéutico comunitario en periodo de pandemia por la COVID-19: estudio observacional, transversal y multicéntrico
Farmacéuticos comunitarios, Vol. 14, Núm. 3, pp. 31-50
-
Enfermedades del esófago (I): enfermedad por reflujo gastroesofágico. Diagnóstico y tratamiento
FMC Formacion Medica Continuada en Atencion Primaria, Vol. 29, Núm. 4, pp. 164-173
-
Enfermedades del esófago (I): enfermedad por reflujo gastroesofágico: diagnóstico y tratamiento
FMC: Formación Médica Continuada en Atención Primaria, Vol. 29, Núm. 4, pp. 164-173
-
Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 22-27
-
Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet
Revista Espanola de Enfermedades Digestivas, Vol. 114
-
Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 8, pp. 481-488
2021
-
Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
Therapeutic Advances in Gastroenterology, Vol. 14
-
Risk of COVID-19 transmission in esophageal, anorectal manometry and 24-hour impedance-pH monitoring
Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 5, pp. 332-338
-
Transitions Over Time: Another Unexplained Aspect of Functional Gastrointestinal Disorders
Mayo Clinic Proceedings
2020
-
2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases
Alimentary Pharmacology and Therapeutics, Vol. 52, Núm. 2, pp. 276-283
-
Fulminant gastrointestinal ischemia due to yeyunal volvulus
Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 10, pp. 809-810
-
Fulminant gastrointestinal ischemia due to yeyunal volvulus
Revista Espanola de Enfermedades Digestivas, Vol. 112
-
Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors’ reply
Alimentary Pharmacology and Therapeutics
-
Obstructed defecation syndrome: A diagnostic and therapeutic challenge
Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 6, pp. 477-482
-
Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review
Therapeutic Advances in Gastroenterology, Vol. 13
-
Síndrome de defecación obstructiva: Un reto diagnóstico y terapéutico
Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 6, pp. 477-482
2019
-
A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain
Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 141-149
-
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms
Therapeutic Advances in Gastroenterology, Vol. 12
-
Differences in the need for adalimumab dose optimization between Crohn’s disease and ulcerative colitis
Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 11, pp. 846-851